Access brought to you by: LOCKSS

Cerebrovascular Disease Clinical Trials

Patients with Mild Ischemic Stroke Benefit from IV-rtPA
Addition of AMPLATZER PFO Occluder to Medical Therapy is Beneficial in Patients with Cryptogenic Stroke and PFO
The EMBRACE Trial: Prolonged Ambulatory Cardiac Monitoring Improves the Detection and Treatment of Atrial Fibrillation in Patients with Cryptogenic Stroke
The Secondary Prevention of Small Subcortical Strokes Trial: Blood Pressure Intervention Results
Outcomes with Apixaban by Type of AF
AXIS 2 Clinical Outcomes No Different than Placebo
AMM Benefits Those Who Fail Antithrombotic Therapy
SPS3 Study Does Not Support the Use of Combination Therapy for Stroke Prevention
Novel Agent NA-1 Proves That Ischemic Neuroprotection is Possible in Older Patients
Increased Bleeding Risk with Concomitant Use of Antiplatelet Therapy: Dabigatran vs Warfarin

Pages